Legislation calls for new urology division within NIH

The CELLEBRATE trial is aiming to provide additional evidence to support the safety and efficacy of iltamiocel.

Rachel Rubin, MD, discusses advancements in sexual health education and guidelines at the AUA meeting.

Jonathan Rubenstein, MD, and Mark Painter answer a question regarding coding for use of the second-generation Calyxo CVAC system.

In this episode, guideline chair Melissa Kaufman, MD, PhD, FACS, highlights key points from the new AUA GSM guideline and illustrates its impact for clinical management of this condition.

"The Inflation Reduction Act was a major step in the right direction. The question now is going to be, are commercial insurers going to follow Medicare and enact the same cap that they have as well," says Benjamin Pockros, MD, MBA.

A recap of the FDA submissions and regulatory decisions in urology from March 2025.